JP3112983B2 - Cosmetics - Google Patents

Cosmetics

Info

Publication number
JP3112983B2
JP3112983B2 JP03156033A JP15603391A JP3112983B2 JP 3112983 B2 JP3112983 B2 JP 3112983B2 JP 03156033 A JP03156033 A JP 03156033A JP 15603391 A JP15603391 A JP 15603391A JP 3112983 B2 JP3112983 B2 JP 3112983B2
Authority
JP
Japan
Prior art keywords
cells
acidophilus
lactic acid
skin
cosmetics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP03156033A
Other languages
Japanese (ja)
Other versions
JPH04356409A (en
Inventor
佳子 向井
健次 下村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP03156033A priority Critical patent/JP3112983B2/en
Publication of JPH04356409A publication Critical patent/JPH04356409A/en
Application granted granted Critical
Publication of JP3112983B2 publication Critical patent/JP3112983B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は保湿性が高く、皮膚を滑
らかにし、若々しい皮膚を保つ化粧品に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic product having a high moisturizing property, making the skin smooth and keeping the youthful skin.

【0002】[0002]

【従来の技術】ラクトバチルス アシドフィルス(Lacto
bacillus acidophilus) はコリネ型菌に属し、ラクトバ
チルス(Lactobacillus )属のサーモバクテリウム(Th
ermobacterium )亜属、グラム陽性悍菌、カタラーゼ陰
性、通性嫌気性、非運動性、無胞子で連鎖状になる場合
もある菌で、病原性はなく、広く食品として利用されて
いる。例えばヨーグルト、醗酵乳酸菌飲料等である。
2. Description of the Related Art Lactobacillus acidophilus (Lacto
bacillus acidophilus belongs to the coryneform bacterium and is a bacterium belonging to the genus Lactobacillus.
ermobacterium), a subgenus, Gram-positive bacterium, catalase-negative, facultatively anaerobic, non-motile, non-spore-forming and sometimes linked, and is not pathogenic and is widely used as food. For example, yogurt, fermented lactic acid bacteria drink and the like.

【0003】一方、化粧品原料として、乳酸菌醗酵代謝
液を用いることはすでに知られているが、その乳酸菌の
種類と製造方法が異なる。従来使用されている菌種はス
トレプトコッカス サーモフィルス(Streptococcus th
ermophilus)を脱脂粉乳、ぶどう糖で培養し、除菌し、
培養液のみを利用している。
[0003] On the other hand, it is already known to use a fermented metabolite of lactic acid bacteria as a raw material for cosmetics, but the type and production method of the lactic acid bacteria are different. Conventionally used strains are Streptococcus thermophilus (Streptococcus th.
ermophilus), cultivated in skim milk powder and glucose, sterilized,
Only the culture solution is used.

【0004】[0004]

【発明が解決しようとする課題】本発明は保湿性が高
く、皮膚を滑らかにし、若々しい皮膚を保つ化粧品であ
って、安全性も高いものを提供することである。
SUMMARY OF THE INVENTION The object of the present invention is to provide a cosmetic product which has a high moisturizing property, smoothes the skin and keeps youthful skin, and which has high safety.

【0005】[0005]

【課題を解決するための手段】本発明者らは、前記の課
題を解決するために鋭意研究を重ねた結果、乳酸菌の一
種であるラクトバチルス アシドフィルスの培養液と菌
体とを微粉砕したものが、化粧品として非常に有効であ
ることを見出し本発明を完成した。すなわち本発明は、
Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, obtained by finely pulverizing a culture solution and cells of Lactobacillus acidophilus, a kind of lactic acid bacterium. However, they found that they were very effective as cosmetics and completed the present invention. That is, the present invention

【0006】 ラクトバチルス アシドフィルス(Lac
tobacillus acidophilus) の菌体と、その醗酵代謝液と
を破砕したものを含む化粧料であり、
[0006] Lactobacillus acidophilus (Lac
tobacillus acidophilus) and its fermentation metabolites.

【0007】 ラクトバチルス アシドフィルス(Lac
tobacillus acidophilus) の菌体と、その醗酵代謝液と
を破砕したものとグリセリンを含む化粧料である。
[0007] Lactobacillus acidophilus (Lac
Tobacillus acidophilus) and its fermentation metabolite are crushed and cosmetics containing glycerin.

【0008】本発明の化粧料の有効成分を製造する方法
はラクトバチルス アシドフィルス(Lactobacillus aci
dophilus) を他の菌が混入しない状態で培養し、培養
後、超音波、フレンチプレス、マイクロフルイダイザー
の何れか又は組合わせて使用して、培養液とともに菌体
を充分に粉砕する。この液を0.2ミクロン以下のメン
ブランフィルターでロ過するか、或いは目的によっては
限外ロ過器で分子量1000〜100000以上の物質
をロ過して除く。
[0008] The method of producing the active ingredient of the cosmetic of the present invention is based on Lactobacillus acidophilus.
dophilus) is cultured in a state in which other bacteria are not mixed, and after the culture, the cells are sufficiently pulverized together with the culture solution using ultrasonic waves, a French press, or a microfluidizer or a combination thereof. This solution is filtered through a membrane filter of 0.2 μm or less, or, depending on the purpose, an ultrafilter is used to remove substances having a molecular weight of 1,000 to 100,000 or more.

【0009】このようにして得た水溶液をクリーム、ロ
ーション、パック、美容液等の様々な剤形の中に配合し
て利用できる。本発明の特徴であるこの水溶液を配合す
ると、保湿性が大きく改善され、皮膚のしっとり感を増
し、小皺を減少させ、肌の荒れを防ぐ効果が大きいこと
が判明した。細胞賦活作用も大きく、且つ安全性も確認
された。また、その他に併用する他の化粧品原料も特に
配合上限定をうけることはないことも明らかになった。
The aqueous solution thus obtained can be used by blending it in various dosage forms such as creams, lotions, packs, and serums. It has been found that when this aqueous solution, which is a feature of the present invention, is blended, the moisturizing properties are greatly improved, the moist feeling of the skin is increased, the fine wrinkles are reduced, and the effect of preventing rough skin is great. The cell activating effect was large, and safety was confirmed. It has also been found that other cosmetic ingredients used in combination are not particularly limited in terms of formulation.

【0010】[0010]

【実施例】以下に実施例により、本発明を更に具体的に
説明するが、本発明は、この実施例によって限定される
ものではない。 (製造例)ラクトバチルス アシドフィルス(Lactobaci
llus acidophilus) (IFO 13951)を表1に示
した培地で37℃で培養後、菌体及び醗酵代謝物をマイ
クロフルイダイザーで1次圧7kg/cm2 で2回処理した
後、0.1ミクロンのメンブランフィルターでロ過し
た。このものの窒素含量は0.12重量%(N)であっ
た。
EXAMPLES The present invention will be described in more detail with reference to the following examples, but the present invention is not limited by these examples. (Production example) Lactobacillus acidophilus
llus acidophilus) (IFO 13951) was cultured at 37 ° C. in the medium shown in Table 1, and the cells and the fermented metabolite were treated twice with a microfluidizer at a primary pressure of 7 kg / cm 2 , and then 0.1 μm. Filtered through a membrane filter. Its nitrogen content was 0.12% by weight (N).

【0011】[0011]

【表1】 [Table 1]

【0012】 (実施例1) ローション 製造例の乳酸菌醗酵代謝液 94.9重量% グリセリン 5.0 〃 パラオキシ安息香酸メチル 0.1 〃(Example 1) Lotion A lactic acid bacterium fermentation metabolite of a production example 94.9% by weight Glycerin 5.0 {Methyl parahydroxybenzoate 0.1}

【0013】 (実施例2) クリーム A スクワラン 20.0重量% ホホバ油 5.0 〃 ミツロウ 5.0 〃 セトステアリルアルコール 2.0 〃 グリセリンモノステアレート 1.0 〃 ソルビタンモノステアレート 2.0 〃 B 精製水 46.9重量% ポリオキシエチレン(20E.O.)ソルビタン モノステアレート 2.0 〃 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 〃 グリセリン 5.0 〃 パラオキシ安息香酸メチル 0.1 〃 C 製造例の乳酸菌醗酵代謝液 10.0重量% AとBをそれぞれ計量し、70℃まで加温し、BにAを
攪拌しつつ徐々に加えたのち、冷却し、50℃でCを加
えてゆっくり攪拌しつつ30℃まで冷却した。
(Example 2) Cream A Squalane 20.0% by weight Jojoba oil 5.0 {Beeswax 5.0} Cetostearyl alcohol 2.0 {Glycerin monostearate 1.0} Sorbitan monostearate 2.0 B Purified water 46.9% by weight Polyoxyethylene (20E.O.) sorbitan monostearate 2.0〃 Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0〃 Glycerin 5.0〃 Methyl paraoxybenzoate 0.1% C Lactic acid bacterium fermentation metabolite of production example 10.0% by weight A and B were respectively weighed, heated to 70 ° C, and A was gradually added to B with stirring, cooled, and cooled to 50 ° C. Then, C was added thereto, and the mixture was cooled to 30 ° C. while stirring slowly.

【0014】(実施例3)実施例2において、グリセリ
ンを水に置き換えたもの。 (比較例1,2,3)前記、実施例1、実施例2、実施
例3の製造例の乳酸菌醗酵代謝液を水に置き換えたもの
をそれぞれ比較例1,2,3とする。
(Example 3) In Example 2, glycerin was replaced with water. (Comparative Examples 1, 2, 3) Comparative examples 1, 2, and 3 were obtained by replacing the lactic acid bacteria fermentation metabolites of the production examples of Examples 1, 2, and 3 with water.

【0015】(効果の確認) (1) 細胞賦活作用 試験方法 カバーカラスの入った径6cmのシャーレにEagle
MEM(牛胎児血清20%)培地を5mlづつ分注する。
JTC−17細胞浮游液を20万個を添加し、5%CO
2 ,36℃の温度下で48時間培養した。その後、緩衝
液PBS(−)(NaCl 8.0g、KCl 0.2
g、Na2 PO4 1.15g、KH2 PO4 0.2
gを含む緩衝液)で2度洗浄後、Eagle MEM
(無血清)培地で、1wt%、2wt%、3wt%、5
wt%の各濃度に希釈した試料(製造例で製造した液を
MEMで各濃度に薄めた液、濃度は製造例の液体換算)
5mlと牛胎児血清0.05mlを加えて、5%CO2 、3
6℃の温度下で6日間培養した後、固定、染色した後、
下記の基準で判定した。
(Confirmation of effect) (1) Cell activation action test method Eagle was placed on a 6 cm diameter petri dish containing a cover crow.
MEM (20% fetal bovine serum) medium is dispensed in 5 ml portions.
Add 200,000 suspensions of JTC-17 cells and add 5% CO
2. The cells were cultured at a temperature of 36 ° C. for 48 hours. Thereafter, the buffer PBS (-) (8.0 g of NaCl, 0.2 g of KCl 0.2
g, Na 2 PO 4 1.15 g, KH 2 PO 4 0.2
g) (buffer containing g), and then washed twice with Eagle MEM.
(Serum-free) 1 wt%, 2 wt%, 3 wt%, 5
A sample diluted to each concentration of wt% (a liquid prepared in the production example diluted to each concentration by MEM, the concentration is a liquid equivalent of the production example)
5 ml and 0.05 ml of fetal calf serum were added, and 5% CO 2 , 3
After culturing at 6 ° C for 6 days, fixation and staining,
The following criteria were used for the determination.

【0016】 判定基準 [1]細胞数による判定 Score −3:Control のほぼ1.5倍(大幅に増加) −2:Control の4/3位(肉眼でも分かる程度に増加) −1:Control よりやや多い(わずかに染色濃度が勝る) 0:Control と同じ 1:Control よりやや劣る(わずかに染色濃度が劣る) 2:Control の2/3位(肉眼でも分かる程度に減少) 3:Control のほぼ半分(大幅に減少) 4:Control の1/3位(細胞数はごく僅か) 5:細胞を認めない [2]細胞形態による判定 Score 0:正常像 1:異常細胞がわずかに認められる(正常細胞が80%以上) 2:異常細胞が認められる(正常細胞が50〜80%位) 3:異常細胞が多数認められる(正常細胞が20〜50%位) 4:殆ど異常細胞である(正常細胞が20以下) 5:正常細胞を認めないJudgment Criteria [1] Judgment by Number of Cells Score -3: Almost 1.5 times as large as Control (substantially increased) -2: 4/3 of Control (increased to the extent that it can be seen with the naked eye) Slightly higher (slightly superior in staining density) 0: Same as Control 1: Slightly inferior to Control (slightly inferior in staining density) 2: 2/3 of Control (reduced to the naked eye) 3: Almost in Control Half (significant reduction) 4: 1/3 position of control (very few cells) 5: No cells are observed [2] Judgment by cell morphology Score 0: Normal image 1: Abnormal cells are slightly observed (Normal) 2: Abnormal cells are observed (normal cells are about 50 to 80%) 3: Many abnormal cells are observed (normal cells are about 20 to 50%) 4: Almost abnormal cells (normal) 5: Normal cells were observed Have

【0017】結 果 表示の仕方は最初の数字は細胞数による判定結果を、括
弧内の数字は細胞形態による判定結果を表す。試料の代
りに水を同量加えたものをブランクとする。結果を表2
に示す。
Results In the manner of display, the first number indicates the determination result based on the number of cells, and the number in parentheses indicates the determination result based on the cell morphology. A blank is prepared by adding the same amount of water in place of the sample. Table 2 shows the results
Shown in

【0018】[0018]

【表2】 ブランク0(3)細胞賦活作用の試験は条件を厳しくし
ているので、ランク3となったがブランクも異常細胞ラ
ンク3なので、皮膚安全上は問題がない。
[Table 2] Blank 0 (3) The cell activation test was conducted under strict conditions, which resulted in rank 3. However, since the blank was also abnormal cell rank 3, there was no problem in skin safety.

【0019】(2) 保湿試験 前記の実施例1、比較例1を検体として、次の試験を行
った。20名の女性の前腕内側部の2cm×2cmに検体2
0μlを均一に塗布する。1人10検体づつ塗布する
が、塗布部位の影響を受けないように同一検体が同じ位
置にならないようにする。塗布前、20分、40分、6
0分、80分経過したのち、高周波電気伝導性測定装置
SKICON−200(IBS社製、波長3.5MH
z、プローグ2mm)でコンダクタンスを測定した。結果
を表3に示す。
(2) Moisturizing Test The following tests were conducted using the above-mentioned Example 1 and Comparative Example 1 as samples. Specimen 2 on 2 cm x 2 cm inside forearm of 20 women
Apply 0 μl uniformly. Apply 10 samples per person, but make sure that the same sample is not in the same position so as not to be affected by the application site. Before application, 20 minutes, 40 minutes, 6
After 0 minute and 80 minutes have elapsed, a high-frequency electric conductivity measuring device SKICON-200 (manufactured by IBS, wavelength 3.5 MH)
z, prog 2 mm). Table 3 shows the results.

【0020】[0020]

【表3】 [Table 3]

【0021】(3) 使用テスト 女性30名を2群に分け顔面を左右に分け、一方を実施
例、もう一方を比較例として毎日、1回以上使用しても
らって、2月後、アンケートした。なお、比較例は実施
例の製造例の乳酸菌醗酵代謝液を水に置き換えたもので
ある。 判定基準は 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例のほうがかなりよい −2 比較例の方が非常によい −3 判定値を合計した値を結果とし、表4に示す。
(3) Usage test Thirty women were divided into two groups, the face was divided into left and right, one was used as an example, and the other was used as a comparative example, and was used at least once a day. In the comparative example, the lactic acid bacteria fermentation metabolite of the production example of the example was replaced with water. The criteria are very good for the example 3 Very good for the example 2 Somewhat better for the example 1 No difference 0 Somewhat better for the comparative example -1 Very good for the comparative example -2 comparison The example is much better. The results obtained by summing the -3 judgment values are shown in Table 4.

【0022】[0022]

【表4】 実施例2と比較例2の方が、判定値が、実施例1と比
較例1より小さくなっているのは、実施例2の方が、乳
酸菌醗酵代謝液以外に保湿効果の良好な成分を多く配合
してあるので、比較例2とくらべて差が小さくなったた
めと考えられる。
[Table 4] The judgment value of Example 2 and Comparative Example 2 is smaller than that of Example 1 and Comparative Example 1 because Example 2 has a component having a good moisturizing effect other than the lactic acid bacteria fermentation metabolite. It is considered that the difference was smaller than that of Comparative Example 2 because a large amount was added.

【0023】[0023]

【発明の効果】本発明の化粧料は、細胞賦活作用効果の
確認試験、保湿試験及び使用テストの結果から明らかな
ように、細胞賦活作用及び保湿効果に優れ、皮膚を滑ら
かにし、小皺を減少せしめ、しかも、肌荒れを防ぐこと
ができ、若々しい皮膚を保つ効果があり、安全性につい
ても問題がない。
EFFECTS OF THE INVENTION The cosmetics of the present invention have excellent cell activating and moisturizing effects, smooth the skin and reduce fine wrinkles, as is clear from the results of the confirmation test, the moisturizing test and the use test of the cell activating effect. At the same time, it can prevent rough skin, has the effect of keeping youthful skin, and has no problem in safety.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 ──────────────────────────────────────────────────続 き Continued on front page (58) Field surveyed (Int.Cl. 7 , DB name) A61K 7/ 00-7/50

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ラクトバチルス アシドフィルス(Lacto
bacillusacidophilus)の菌体と、その醗酵代謝液とを破
砕したものを含む化粧料。
Claims: 1. Lactobacillus acidophilus (Lacto
A cosmetic comprising bacillus cells of Bacillus acidophilus) and a fermentation metabolite thereof.
【請求項2】 ラクトバチルス アシドフィルス(Lacto
bacillus acidophilus) の菌体と、その醗酵代謝液とを
破砕したものとグリセリンを含む化粧料。
2. Lactobacillus acidophilus (Lacto
(Bacillus acidophilus) and its fermentation metabolite are crushed and cosmetics containing glycerin.
JP03156033A 1991-05-31 1991-05-31 Cosmetics Expired - Lifetime JP3112983B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03156033A JP3112983B2 (en) 1991-05-31 1991-05-31 Cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03156033A JP3112983B2 (en) 1991-05-31 1991-05-31 Cosmetics

Publications (2)

Publication Number Publication Date
JPH04356409A JPH04356409A (en) 1992-12-10
JP3112983B2 true JP3112983B2 (en) 2000-11-27

Family

ID=15618851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03156033A Expired - Lifetime JP3112983B2 (en) 1991-05-31 1991-05-31 Cosmetics

Country Status (1)

Country Link
JP (1) JP3112983B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7510734B2 (en) 2004-03-04 2009-03-31 E-L Management Corporation Skin treatment method with Lactobacillus extract

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (en) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere USE OF LACTIC BACTERIA TO INCREASE THE LEVEL OF CERAMIDES OF THE SKIN AND MUCOSA, AND SUITABLE DERMATOLOGICAL AND COSMETIC COMPOSITIONS
JP3795011B2 (en) * 2002-12-16 2006-07-12 株式会社ヤクルト本社 Moisturizer and cosmetics containing the same
FR2889057B1 (en) * 2005-08-01 2008-07-18 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF SENSITIVE OR DRY SKINS
KR101106077B1 (en) * 2006-08-10 2012-01-18 하우스 웰니스 푸드 코퍼레이션 Moisturizing agent
US8465731B2 (en) 2010-03-12 2013-06-18 Elc Management, Llc Probiotic color cosmetic compositions and methods
KR101693574B1 (en) * 2014-09-23 2017-01-06 한국 한의학 연구원 Composition for moisturizing skin and anti-wrinkle comprising tyndalized lactic acid bacteria as effective component

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7510734B2 (en) 2004-03-04 2009-03-31 E-L Management Corporation Skin treatment method with Lactobacillus extract
EP2514427A1 (en) 2004-03-04 2012-10-24 E-L Management Corp. Skin treatment method with lactobacillus extract

Also Published As

Publication number Publication date
JPH04356409A (en) 1992-12-10

Similar Documents

Publication Publication Date Title
KR960005736B1 (en) Novel production process of hyaluronic acid
EP1344528B1 (en) External skin preparations and process for producing the same
EP2095820A1 (en) Fermented milk for improving and/or treating skin and method for producing the same
KR101719223B1 (en) Cosmetic composition for promoting ceramide biosynthesis containing Panax ginseng, honey, and propolis fermented by kimchi lactic acid bacteria
CN105451751B (en) Composition for removing skin cutin material containing green tea lactobacillus
KR20180108504A (en) Fermented product of colostrum and a cosmetic composition using the same
KR100302504B1 (en) Fermented product using lactic acid bacteria and cosmetic composition
KR100996056B1 (en) Lactobacillus brevis HY7401 having protective effect against colitis and products containing thereof as effective component
JP2002187838A (en) Skin care preparation
JP3112983B2 (en) Cosmetics
JP3184114B2 (en) Moisturizer
JP2002191387A (en) Clear supernatant culture liquid of lactobacillus, method for manufacturing the same, and skin care preparation using the same
JP5048935B2 (en) Moisturizer
EP2609927A1 (en) Cytoprotective agent
JP2002193735A (en) Skin care composition for external use and method of producing the same
TWI636797B (en) Moisturizer
KR100302505B1 (en) Fermented product using lactic acid bacteria and cosmetic composition
EP0868908B1 (en) Cosmetic material
TWI701033B (en) Bundling energy enhancer of collagen fiber
KR102026366B1 (en) Cosmetic composition comprising whey fermented product of complex probiotics, production methode thereof and functional cosmetic composition comprising the same
JPH04124115A (en) External preparation
EP4134440A1 (en) Malva sylvestris fermentation product and use thereof
TWI820499B (en) Probiotic liquid culture and its use for improving skin-related conditions
TW201309339A (en) Whitening the skin with products obtained from liquid culture of Bifidobacterium spp.
JPH0240643B2 (en)

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110922

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110922

Year of fee payment: 11